サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1352917

禁煙・ニコチン依存症治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測

Global Smoking Cessation and Nicotine De-Addiction Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 126 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
禁煙・ニコチン依存症治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測
出版日: 2023年09月01日
発行: Value Market Research
ページ情報: 英文 126 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

禁煙・ニコチン依存症治療市場の世界需要は、調査期間2023年～2030年のCAGR 12.32%で、2022年の137億6,000万米ドルから2030年にはほぼ391億5,000万米ドルの市場規模に達すると推定されます。

禁煙・ニコチン依存症治療は、たばこ中毒者の禁煙を助ける方法です。喫煙は健康だけでなく環境にも有害であるため、これらの製品や治療法は非常に求められています。禁煙やニコチン依存症治療のためのさまざまな治療法も開発されています。これは、禁煙のための治療法を導入する企業によって引き起こされています。禁煙・ニコチン除去補助剤として市場に出回っている有名なニコチン置換療法（NRT）製品ブランドには、Nicotex、Nicogum、Smokefree、KwikNicなどがあります。タバコの売上増加の主な要因はニコチン中毒です。そのため、ニコチン・ガムやニコチン・パッチなどのニコチン依存症治療グッズが市場に出回っています。

市場力学：

禁煙補助剤に対する世界の需要は、禁煙を試みる人が増えるにつれて禁煙・ニコチン依存症治療市場を劇的に拡大させています。また、電子タバコやニコチン脱中毒製品に対する需要の高まりにより、市場の成長も予想されます。しかし、市場参加者は、技術的な問題や機器に関連する健康リスクの増加によるメーカーや企業による製品回収など、大きな障害に直面する可能性があります。それにもかかわらず、一般市民の健康や環境に関心を持つ人々や政府が増加しています。こうして、市場は前進しています。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは禁煙・ニコチン依存症治療の世界市場における各セグメントを包括的に評価することもできます。禁煙・ニコチン依存症治療産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカの禁煙・ニコチン依存症治療市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、本レポートでは、著名な全地域における個々の用途セグメントの需要・推定・予測に焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 禁煙・ニコチン依存症治療-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 世界の禁煙・ニコチン依存症治療市場製品タイプ別分析

  • 製品タイプ別概要
  • 実績データと予測データ
  • 製品タイプ別分析
  • 製品（ニコチン入り）（OTC製品、処方製品）
  • 処方製品（ニコチンスプレー（NRT）、ニコチン吸入器（NRT））
  • 製品（ニコチンなし）
  • 処方製品

第7章 禁煙・ニコチン依存症治療の世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • オンライン
  • オフライン

第8章 世界の禁煙・ニコチン依存症治療市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東とアフリカ

第9章 禁煙・ニコチン依存症治療企業の競合情勢

  • 禁煙・ニコチン依存症治療市場の競合
  • 提携／協力／合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • 22nd Century Group Inc.
  • Alkalon A/S
  • Cipla Ltd.
  • GlaxoSmithKline plc（GSK）
  • ITC Ltd.
  • Johnson & Johnson（J&J）
  • JUUL Labs Inc.
  • Pfizer Inc.
  • Strides Pharma Science Ltd.
  • Takeda Pharmaceutical Company Ltd.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Product (With Nicotine) (OTC Products, Prescription Products) Market Sales by Geography (USD MN)
  • Prescription Products (Nicotine Sprays (NRT), Nicotine Inhalers (NRT)) Market Sales by Geography (USD MN)
  • Product (Without Nicotine) Market Sales by Geography (USD MN)
  • Prescription Products Market Sales by Geography (USD MN)
  • Analysis Market by Distribution Channel (USD MN)
  • Online Market Sales by Geography (USD MN)
  • Offline Market Sales by Geography (USD MN)
  • Global Smoking Cessation And Nicotine De-Addiction Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Smoking Cessation And Nicotine De-Addiction Report
  • Market Research Process
  • Market Research Methodology
  • Global Smoking Cessation And Nicotine De-Addiction Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Product (With Nicotine) (OTC Products, Prescription Products) Market Sales by Geography (USD MN)
  • Prescription Products (Nicotine Sprays (NRT), Nicotine Inhalers (NRT)) Market Sales by Geography (USD MN)
  • Product (Without Nicotine) Market Sales by Geography (USD MN)
  • Prescription Products Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Online Market Sales by Geography (USD MN)
  • Offline Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218851

The global demand for Smoking Cessation and Nicotine De-Addiction Market is presumed to reach the market size of nearly USD 39.15 BN by 2030 from USD 13.76 BN in 2022 with a CAGR of 12.32% under the study period 2023 - 2030 .

Smoking cessation and nicotine de-addiction are methods that help cigarette addicts stop smoking. The products and therapies are highly sought after as smoking is injurious to health as well as the environment. Different therapies have also been developed for smoking cessation and nicotine de-addiction goods. This has been sparked by companies introducing treatments for quitting. Some of the well-known nicotine replacement therapy (NRT) product brands on the market for smoking cessation and nicotine de-addiction aids include Nicotex, Nicogum, Smokefree, and KwikNic. A key contributing factor to increased cigarette sales is nicotine addiction. As a result, the market is marketed with nicotine de-addiction goods, including nicotine gum and patches.

MARKET DYNAMICS:

The worldwide demand for smoking cessation aids has dramatically expanded the Smoking cessation and nicotine de-addiction market as more people try to give up smoking. The market is also anticipated to grow due to the rising demand for e-cigarettes and nicotine de-addiction products. However, the market players may face significant obstacles, such as product recalls by the manufacturer and companies due to increased technical issues and health risks connected to devices. Nonetheless, an increasing number of people and government are getting concerned about the general health of the public and the environment. Thus, propelling the market forward.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of smoking cessation and nicotine de-addiction. The growth and trends of smoking cessation and nicotine de-addiction industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the smoking cessation and nicotine de-addiction market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Product (With Nicotine) (OTC Products, Prescription Products)
  • Prescription Products (Nicotine Sprays (NRT), Nicotine Inhalers (NRT))
  • Product (Without Nicotine)
  • Prescription Products

By Distribution Channel

  • Online
  • Offline

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Smoking Cessation and Nicotine De-Addiction market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the smoking cessation and nicotine de-addiction market include 22nd Century Group Inc., Alkalon A/S, Cipla Ltd., GlaxoSmithKline plc (GSK), ITC Ltd., Johnson & Johnson (J&J), JUUL Labs Inc., Pfizer Inc., Strides Pharma Science Ltd., Takeda Pharmaceutical Company Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SMOKING CESSATION AND NICOTINE DE-ADDICTION - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Distribution Channel
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Product (With Nicotine) (OTC Products, Prescription Products) Historic and Forecast Sales by Regions
  • 6.5 Prescription Products (Nicotine Sprays (NRT), Nicotine Inhalers (NRT)) Historic and Forecast Sales by Regions
  • 6.6 Product (Without Nicotine) Historic and Forecast Sales by Regions
  • 6.7 Prescription Products Historic and Forecast Sales by Regions

7 . GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1 Overview by Distribution Channel
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Distribution Channel
  • 7.4 Online Historic and Forecast Sales by Regions
  • 7.5 Offline Historic and Forecast Sales by Regions

8 . GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE SMOKING CESSATION AND NICOTINE DE-ADDICTION COMPANIES

  • 9.1. Smoking Cessation And Nicotine De-Addiction Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF SMOKING CESSATION AND NICOTINE DE-ADDICTION INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. 22nd Century Group Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Alkalon A/S
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Cipla Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. GlaxoSmithKline plc (GSK)
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. ITC Ltd.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Johnson & Johnson (J&J)
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. JUUL Labs Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Pfizer Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Strides Pharma Science Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Takeda Pharmaceutical Company Ltd.
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies